Successful adalimumab graded challenge after allergic delayed reaction to golimumab in a woman with rheumatoid arthritis

Federica Rivolta; Andrea Sangalli; Camilla Cappelletti; Alessandra Chiei Gallo; Marco Dubini; Valerio Pravettoni

doi:10.1002/ccr3.7067

Successful adalimumab graded challenge after allergic delayed reaction to golimumab in a woman with rheumatoid arthritis

Clin Case Rep. 2023 Mar 24;11(3):e7067. doi: 10.1002/ccr3.7067. eCollection 2023 Mar.

Authors

Federica Rivolta¹, Andrea Sangalli², Camilla Cappelletti², Alessandra Chiei Gallo², Marco Dubini², Valerio Pravettoni¹

Affiliations

¹ Department of Internal Medicine Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milan Italy.
² Allergy and Clinical Immunology Residency University of Milan Milan Italy.

Abstract

A graded challenge with adalimumab could be safe in case of a delayed allergic reaction to golimumab, after a detailed allergological evaluation and the exclusion of allergic sensitization using skin tests.

Keywords: adalimumab; anti‐TNF agent; delayed reaction to biologic agent; golimumab; hypersensitivity reaction to biological; hypersensitivity to biologic agent.

Publication types

Case Reports